Acute renal failure early after heart transplantation: risk factors and clinical consequences

Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S. Acute renal failure early after heart transplantation: risk factors and clinical consequences. 
Clin Transplant 2010: 24: E207–E213. © 2010 John Wiley & Sons A/S. :  Limited i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical transplantation 2010-11, Vol.24 (6), p.E207-E213
Hauptverfasser: Gude, Einar, Andreassen, Arne K., Arora, Satish, Gullestad, Lars, Grov, Ingelin, Hartmann, Anders, Leivestad, Torbjørn, Fiane, Arnt E., Geiran, Odd R., Vardal, Mari, Simonsen, Svein
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S. Acute renal failure early after heart transplantation: risk factors and clinical consequences. 
Clin Transplant 2010: 24: E207–E213. © 2010 John Wiley & Sons A/S. :  Limited information exists about acute renal failure (ARF) early after heart transplantation (HTx). We correlated pre‐, per‐, and post‐operative patient and donor parameters to the risk of developing ARF. We also analyzed the consequences of ARF on kidney function after HTx, risk of later need for chronic dialysis or kidney transplantation, and mortality. In a retrospective study from 1983 to 2007, 145 (25%) of 585 HTx recipients developed ARF, defined as ≥26.4 micromol/L or ≥50% increase in serum creatinine from pre‐operatively to the seventh day post‐HTx and/or the need of early post‐operative dialysis. Independent risk factors for ARF were intravenous cyclosporine immediately post‐operatively (odds ratio [OR] 2.16, 95% CI 1.34–3.50, p = 0.02), donor age (OR 1.02, 95% CI 1.00–1.04, p = 0.02), and pre‐operative cardiac output (OR 1.38, 95% CI 1.12–1.71, p = 0.003). The development of ARF was a predictor for short‐term survival (≤3 months) ranging from 98% for patients who improved their creatinine after HTx vs. 79% for those in need of dialysis (p 
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2010.01225.x